Imaging Genetics and Genomics in Psychiatry: A Critical Review of Progress and Potential
- PMID: 28283186
- PMCID: PMC5505787
- DOI: 10.1016/j.biopsych.2016.12.030
Imaging Genetics and Genomics in Psychiatry: A Critical Review of Progress and Potential
Abstract
Imaging genetics and genomics research has begun to provide insight into the molecular and genetic architecture of neural phenotypes and the neural mechanisms through which genetic risk for psychopathology may emerge. As it approaches its third decade, imaging genetics is confronted by many challenges, including the proliferation of studies using small sample sizes and diverse designs, limited replication, problems with harmonization of neural phenotypes for meta-analysis, unclear mechanisms, and evidence that effect sizes may be more modest than originally posited, with increasing evidence of polygenicity. These concerns have encouraged the field to grow in many new directions, including the development of consortia and large-scale data collection projects and the use of novel methods (e.g., polygenic approaches, machine learning) that enhance the quality of imaging genetic studies but also introduce new challenges. We critically review progress in imaging genetics and offer suggestions and highlight potential pitfalls of novel approaches. Ultimately, the strength of imaging genetics and genomics lies in their translational and integrative potential with other research approaches (e.g., nonhuman animal models, psychiatric genetics, pharmacologic challenge) to elucidate brain-based pathways that give rise to the vast individual differences in behavior as well as risk for psychopathology.
Keywords: Candidate; Genetics; Genomics; Imaging; MRI; Neurogenetics; Polygenic.
Copyright © 2017 Society of Biological Psychiatry. All rights reserved.
Conflict of interest statement
The authors report no biomedical financial interests or potential conflicts of interest.
Figures
References
-
- Bogdan R, Hyde LW, Hariri AR. A neurogenetics approach to understanding individual differences in brain, behavior, and risk for psychopathology. Molecular psychiatry. 2013;18:288–299. - PubMed
-
- Pohjalainen T, Rinne JO, Nagren K, Lehikoinen P, Anttila K, Syvalahti EK, et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Molecular psychiatry. 1998;3:256–260. - PubMed
-
- Laruelle M, Gelernter J, Innis RB. D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene. Molecular psychiatry. 1998;3:261–265. - PubMed
-
- Heinz A, Jones DW, Mazzanti C, Goldman D, Ragan P, Hommer D, et al. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biological psychiatry. 2000;47:643–649. - PubMed
-
- Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, et al. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2000;22:133–139. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
